Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 8 | 41772887 | intron variant | G/A | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 8 | 41772887 | intron variant | G/A | snv | 0.33 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
8 | 41772929 | intron variant | G/A | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 41772929 | intron variant | G/A | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 41772929 | intron variant | G/A | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 41772929 | intron variant | G/A | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 41750197 | intron variant | G/A | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 41655063 | 3 prime UTR variant | AGAGTCTATACAGC/-;AGAGTCTATACAGCAGAGTCTATACAGC | delins |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
8 | 41655063 | 3 prime UTR variant | AGAGTCTATACAGC/-;AGAGTCTATACAGCAGAGTCTATACAGC | delins |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
8 | 41655063 | 3 prime UTR variant | AGAGTCTATACAGC/-;AGAGTCTATACAGCAGAGTCTATACAGC | delins |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
1.000 | 0.080 | 8 | 41666227 | intron variant | G/A | snv | 0.24 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
8 | 41803336 | intron variant | C/A | snv | 0.80 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 41729232 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
8 | 41683104 | intron variant | A/G | snv | 1.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
8 | 41683104 | intron variant | A/G | snv | 1.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
8 | 41691973 | intron variant | G/A | snv | 2.0E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
8 | 41714203 | missense variant | C/G;T | snv | 4.8E-06; 2.4E-05 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
8 | 41771132 | intron variant | A/G | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 41708865 | synonymous variant | C/T | snv | 1.6E-05 | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
8 | 41708865 | synonymous variant | C/T | snv | 1.6E-05 | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.080 | 8 | 41688541 | stop gained | G/A | snv | 4.0E-06 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.080 | 8 | 41684619 | stop gained | G/A | snv | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2003 | 2003 | |||||||
|
8 | 41787343 | intron variant | T/C | snv | 0.79 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.080 | 8 | 41708992 | intron variant | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
8 | 41774712 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |